Weight changes with depot neuroleptic maintenance therapy.

  title={Weight changes with depot neuroleptic maintenance therapy.},
  author={David A. Johnson and Maggie Breen},
  journal={Acta psychiatrica Scandinavica},
  volume={59 5},
A prospective study of schizophrenic patients prescribed injectable depot neuroleptic drugs as maintenance therapy showed a clinically significant weight gain in 55% of patients. No significant difference was shown between flupenthixol decanoate and fluphenazine decanoate, nor was a clinically meaningful relationship shown with dose, or the use of anti… CONTINUE READING